Implantable Cardioverter Defibrillators (ICD) Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Implantable Cardioverter Defibrillators Market Report Overview
The implantable cardioverter defibrillators market size was $2.76 billion in 2023. The market is expected to register a modest CAGR of more than 2% during 2023-2033. An implantable cardioverter defibrillator (ICD) is an electronic device that monitors the heart’s rhythm and delivers electric pulses if it detects an arrhythmia to restore the heart’s natural rhythm.
Implantable Cardioverter Defibrillators Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights into the Implantable Cardioverter Defibrillators Market Forecast
The implantable cardioverter defibrillators market research report is built to visualize quantitative market trends within the cardiovascular devices therapeutic area. The model discusses in detail the impact of COVID-19 on the implantable cardioverter defibrillators market for 2020 and beyond. Each of the covered 39 countries’ color-coded and fully sourced market model is equipped with epidemiology-based indications with procedure volumes.
Market Size (2023) | $2.76 billion |
CAGR (2023-2033) | >2% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Segments | · Dual Chamber Implantable Cardioverter Defibrillators (ICD)
· Single Chamber Implantable Cardioverter Defibrillators (ICD) · Subcutaneous Implantable Cardioverter Defibrillators (ICD) |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Leading Companies | · Medtronic Plc
· Abbott Laboratories · Boston Scientific Corp · Biotronik SE & Co KG · MicroPort Scientific Corp |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Implantable Cardioverter Defibrillators Market Dynamics
The ICD market is expected to stably grow over the forecast period because of the increasing population at risk of sudden cardiac arrest. Advancing technology will propel the use of ICDs with future improvements addressing the current limitations of the system.
Implantable Cardioverter Defibrillators Market Segments
The implantable cardioverter defibrillators market can be segmented into dual chamber implantable cardioverter defibrillators (ICD), single chamber implantable cardioverter defibrillators (ICD), and subcutaneous implantable cardioverter defibrillators (ICD). Dual chamber implantable cardioverter defibrillators (ICD) led the implantable cardioverter defibrillators market in 2023. These devices monitor the electrical activity in two chambers of the heart and deliver electric pulses to one or both chambers in the event of an arrhythmia.
Implantable Cardioverter Defibrillators Market Analysis by Segments, 2023 (%)
Buy the Full Report to Know More about the Segments in the Implantable Cardioverter Defibrillators Market
Implantable Cardioverter Defibrillators Market Segmentation by Regions
The key regions in the implantable cardioverter defibrillators market are North America, Europe, the Asia-Pacific, South Central America, and the Middle East and Africa. North America dominated the market in 2023 and is expected to retain its position during the forecast period. The US undoubtedly was the largest contributor to the regional market. The aging population in the US and Canada will boost the size of the current ICD market in the region and provide strong potential, prevalence of diabetes, obesity, and high blood pressure which increase the risk of patients experiencing sudden cardiac arrest will drive the market growth during the projected period.
Implantable Cardioverter Defibrillators Market Analysis by Regions, 2023 (%)
Buy the Full Report to Know More about the Regions in the Implantable Cardioverter Defibrillators Market
Implantable Cardioverter Defibrillators Market - Competitive Landscape
A few of the leading companies in the implantable cardioverter defibrillators market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, Biotronik SE & Co KG, and MicroPort Scientific Corp, among others. Medtronic Plc accounted for the largest implantable cardioverter defibrillators market share in 2023.
Implantable Cardioverter Defibrillators Market Analysis by Companies, 2023 (%)
Buy the Full Report to Know More about the Companies in the Implantable Cardioverter Defibrillators Market
Segments Covered in the Report
Implantable Cardioverter Defibrillators Segment Outlook (Value, $ Billion, 2015-2033)
- Dual Chamber Implantable Cardioverter Defibrillators (ICD)
- Single Chamber Implantable Cardioverter Defibrillators (ICD)
- Subcutaneous Implantable Cardioverter Defibrillators (ICD)
Implantable Cardioverter Defibrillators Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East and Africa
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
- CMO executives who must have deep understanding of the implantable cardioverter defibrillators marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base to make decisions about supplier selection and management.
- Private equity investors who need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to:
- Understand the impact of COVID-19 on the implantable cardioverter defibrillators market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the implantable cardioverter defibrillators market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the implantable cardioverter defibrillators market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific implantable cardioverter defibrillators market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Abbott Laboratories
Boston Scientific Corp
Biotronik SE & Co KG
MicroPort Scientific Corp
Frequently asked questions
-
What was the implantable cardioverter defibrillators market size in 2023?
The implantable cardioverter defibrillators market size was $2.76 billion in 2023.
-
What will the growth rate of the implantable cardioverter defibrillators market be during the forecast period?
The implantable cardioverter defibrillators market is expected to register growth at a CAGR of more than 2% during 2023-2033.
-
Which was the leading segment of the implantable cardioverter defibrillators market in 2023?
Dual chamber implantable cardioverter defibrillators (ICD) led the implantable cardioverter defibrillators market in 2023.
-
Which region held the largest share of the implantable cardioverter defibrillators market in 2023?
North America accounted for the largest implantable cardioverter defibrillators market share in 2023.
-
Which are the major players operating in the implantable cardioverter defibrillators market?
A few of the leading companies in the implantable cardioverter defibrillators market are Medtronic Plc, Abbott Laboratories, Boston Scientific Corp, Biotronik SE & Co KG, and MicroPort Scientific Corp, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.